Context Therapeutics Inc. · NASDAQ:CNTX
Octagon Capital Advisors LP's stake in Context Therapeutics Inc. fell to 3.30% (Schedule 13G/A)
Event Jun 30, 2026 · Filed Jul 31, 2026
Octagon Capital Advisors LP's stake in Context Therapeutics Inc. fell to 3.30%, 3,050,000 shares, as a passive investor on Jun 30, 2026. Filed Jul 31, 2026 (Schedule 13G/A).
- Stake
- 3.30%
- Shares
- 3,050,000
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Octagon Capital Advisors LP | 3.30% | 3,050,000 |
| Octagon Investments Master Fund LP | 3.30% | 3,050,000 |
| Ting Jia | 3.30% | 3,050,000 |
Source
Related
- Context Therapeutics Inc.
- Octagon Capital Advisors LP
- Context Therapeutics Inc. shareholders
- Schedule 13G · Octagon Capital Advisors LP · May 14, 2026
- Schedule 13G/A · Mpm Bioimpact LLC · Aug 14, 2026
- Schedule 13G/A · Blue Owl Capital Holdings LP · Aug 12, 2026
- Schedule 13G · BlackRock, Inc. · Jul 27, 2026
- Schedule 13G/A · Great Point Partners LLC · May 15, 2026
- Schedule 13G/A · Blue Owl Capital Holdings LP · May 14, 2026